Literature DB >> 34519940

Long non-coding RNA VPS9D1-AS1 promotes growth of colon adenocarcinoma by sponging miR-1301-3p and CLDN1.

Wei Liu1.   

Abstract

Colon adenocarcinoma is a frequent malignancy among all colon cancer types. Long non-coding RNAs (lncRNAs) are involved in the progression of colon adenocarcinoma. This study aimed to uncover the molecular mechanism of VPS9D1-AS1 in regulating colon adenocarcinoma development. Quantitative reverse transcription-polymerase chain reaction (RT-qPCR) revealed that VPS9D1-AS1 expression was markedly upregulated in colon adenocarcinoma tissues and cell lines. Cell functional experiments showed that knockdown of VPS9D1-AS1 repressed the growth and invasion of colon adenocarcinoma cells but upregulated cell apoptosis. In addition, we confirmed the interaction of VPS9D1-AS1-miR-1301-3p-CLDN1 using a luciferase assay. Downregulation of miR-1301-3p promoted the progression of colon adenocarcinoma cells. In conclusion, VPS9D1-AS1 facilitated cell growth and suppressed apoptosis of colon adenocarcinoma cells by sponging miR-1301-3p and upregulating CLDN1, which may be effective therapeutic strategies for patients with colon adenocarcinoma.
© 2021. Japan Human Cell Society.

Entities:  

Keywords:  Apoptosis; CLDN1; Colon adenocarcinoma; Invasion; Proliferation; VPS9D1-AS1; miR-1301-3p

Mesh:

Substances:

Year:  2021        PMID: 34519940     DOI: 10.1007/s13577-021-00604-1

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.374


  43 in total

1.  A novel activating mutation of the K-ras gene in human primary colon adenocarcinoma.

Authors:  K Tsukuda; M Tanino; H Soga; N Shimizu; K Shimizu
Journal:  Biochem Biophys Res Commun       Date:  2000-11-30       Impact factor: 3.575

Review 2.  Long Noncoding RNA and Cancer: A New Paradigm.

Authors:  Arunoday Bhan; Milad Soleimani; Subhrangsu S Mandal
Journal:  Cancer Res       Date:  2017-07-12       Impact factor: 12.701

3.  ZEB1 activated-VPS9D1-AS1 promotes the tumorigenesis and progression of prostate cancer by sponging miR-4739 to upregulate MEF2D.

Authors:  Xiaobin Wang; Qiangjun Chen; Xi Wang; Wensheng Li; Guoqiang Yu; Zhiyi Zhu; Weitao Zhang
Journal:  Biomed Pharmacother       Date:  2019-12-30       Impact factor: 6.529

4.  Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells.

Authors:  Jungil Hong; Hong Lu; Xiaofeng Meng; Jae-Ha Ryu; Yukihiko Hara; Chung S Yang
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

5.  Functional characterization of the long noncoding RNA MIR22HG as a tumour suppressor in cervical cancer by targeting IGF2BP2.

Authors:  J Shu; D Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-08       Impact factor: 3.507

6.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

7.  Induction of Apoptosis and Cell Cycle Arrest by Flavokawain C on HT-29 Human Colon Adenocarcinoma via Enhancement of Reactive Oxygen Species Generation, Upregulation of p21, p27, and GADD153, and Inactivation of Inhibitor of Apoptosis Proteins.

Authors:  Chung-Weng Phang; Saiful Anuar Karsani; Sri Nurestri Abd Malek
Journal:  Pharmacogn Mag       Date:  2017-07-11       Impact factor: 1.085

8.  LncBook: a curated knowledgebase of human long non-coding RNAs.

Authors:  Lina Ma; Jiabao Cao; Lin Liu; Qiang Du; Zhao Li; Dong Zou; Vladimir B Bajic; Zhang Zhang
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

9.  LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression.

Authors:  Mengfei Yao; Xiaolei Shi; Yue Li; Yutian Xiao; William Butler; Yongqiang Huang; Leilei Du; Tianqi Wu; Xiaojie Bian; Guohai Shi; Dingwei Ye; Guohui Fu; Jianhua Wang; Shancheng Ren
Journal:  Cell Death Dis       Date:  2020-08-15       Impact factor: 8.469

10.  lncRNA LCPAT1 Upregulation Promotes Breast Cancer Progression via Enhancing MFAP2 Transcription.

Authors:  Xue Gong; Tuozhou Dong; Ming Niu; Xiaoshuan Liang; Shanshan Sun; Youxue Zhang; Yue Li; Dalin Li
Journal:  Mol Ther Nucleic Acids       Date:  2020-07-10       Impact factor: 10.183

View more
  3 in total

1.  Puerarin: A Potential Therapeutic for Colon Adenocarcinoma (COAD) Patients Suffering From SARS-CoV-2 Infection.

Authors:  Weizheng Liang; Xiushen Li; Yue Yao; Qingxue Meng; Xueliang Wu; Hao Wang; Jun Xue
Journal:  Front Pharmacol       Date:  2022-05-23       Impact factor: 5.988

Review 2.  Aberrant Expression of miR-1301 in Human Cancer.

Authors:  Chenming Zhong; Yiyao Dong; Qiudan Zhang; Chunhui Yuan; Shiwei Duan
Journal:  Front Oncol       Date:  2022-01-05       Impact factor: 6.244

3.  A novel necroptosis-related lncRNAs signature effectively predicts the prognosis for osteosarcoma and is associated with immunity.

Authors:  Binfeng Liu; Chengyao Feng; Zhongyue Liu; Chao Tu; Zhihong Li
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.